Infosys buyback offer closed with overwhelming response as 82.6 crore shares tendered against 10 crore target. Institutional investors led participation while promoters stayed out. Discover key details.
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Pine Labs IPO concludes with 2.48x overall subscription. Employee portion sees strong 7.78x demand while QIBs show muted interest. Grey market premium remains flat.
The Studds Accessories IPO witnessed massive investor demand, with the issue subscribed 73 times on final day. NII and QIB portions saw overwhelming response as GMP signals strong listing gains.
Lenskart's massive ₹7,278 crore IPO witnesses overwhelming response with full subscription on opening day. Strong QIB and retail participation indicate massive investor confidence in the eyewear giant's market potential.
The Midwest IPO witnessed unprecedented demand with 92.3 times subscription. NII and QIB portions saw massive interest while GMP signals strong listing gains. Complete breakdown inside.